Contact Francesca

Speaking Engagements

  

2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immunotherapy.

06-08 December 2022
  

The Vice President of Discovery and Translational Research at Deverra Therapeutics, Erika von Euw, highly recommends attending the upcoming CAR-TCR Summit if you work in cell therapy. Last year marked a significant milestone in the field of cell therapy with the development of CAR-T therapies that have proven to be curative.

As a result of t

29 August-01 September 2023